Related Experiment Video
Updated: Aug 1, 2025

12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.8K
Retroperitoneal desmoid-type fibromatosis: a case report
M Hadi El Charif1, Hawraa Tarhini1, David Dushfunian2
1Department of Internal Medicine.
Annals of Medicine and Surgery (2012)
|April 28, 2023
Summary
This report details two rare cases of sporadic retroperitoneal desmoid-type fibromatosis (DF). Surgical resection was the primary treatment, highlighting the need for further research into managing this aggressive soft tissue sarcoma.
Area of Science:
- Oncology
- Surgical Pathology
- Radiology
Background:
- Desmoid-type fibromatosis (DF) is a rare soft tissue sarcoma, typically found in the anterior abdominal wall.
- Retroperitoneal DF is exceptionally rare, often associated with familial syndromes, making sporadic cases noteworthy.
- Reporting experiences with retroperitoneal DF is crucial for understanding oncological outcomes and management strategies.
Observation:
- Two patients presented with sporadic retroperitoneal DF, a rare clinical presentation.
- One patient experienced urinary obstruction due to tumor extension into the kidney, requiring surgical resection.
- The second patient, with a history of recurrent DF, was incidentally diagnosed with retroperitoneal DF, which recurred after initial treatment.
Findings:
- Both cases necessitated surgical tumor resection due to symptomatic presentation and as a curative measure.
- Recurrence of DF significantly impacts patient quality of life, as observed in one case.
- Histopathological and radiological features of these rare retroperitoneal DF cases are detailed.
Implications:
- These cases contribute to the limited literature on retroperitoneal DF, particularly sporadic forms.
- Findings may inform the development of practice-changing recommendations and guidelines for this rare condition.
- Further research is warranted to optimize management and improve outcomes for patients with retroperitoneal DF.

